Connection

Johan Neyts to Antiviral Agents

This is a "connection" page, showing publications Johan Neyts has written about Antiviral Agents.
Connection Strength

1.388
  1. PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases. J Antimicrob Chemother. 2018 12 01; 73(12):3375-3384.
    View in: PubMed
    Score: 0.074
  2. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res. 2018 05; 153:85-94.
    View in: PubMed
    Score: 0.070
  3. The path towards effective antivirals against rabies. Vaccine. 2019 08 02; 37(33):4660-4662.
    View in: PubMed
    Score: 0.069
  4. Rational design of antiviral drug combinations based on equipotency using HCV subgenomic replicon as an in vitro model. Antiviral Res. 2018 01; 149:150-153.
    View in: PubMed
    Score: 0.068
  5. Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antivirals. Antiviral Res. 2017 Sep; 145:82-86.
    View in: PubMed
    Score: 0.067
  6. A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. J Virol Methods. 2012 Aug; 183(2):176-9.
    View in: PubMed
    Score: 0.047
  7. Molecular strategies to inhibit the replication of RNA viruses. Antiviral Res. 2008 Apr; 78(1):9-25.
    View in: PubMed
    Score: 0.035
  8. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J Virol. 2005 Feb; 79(3):1943-7.
    View in: PubMed
    Score: 0.028
  9. Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model. J Infect Dis. 2021 09 01; 224(5):749-753.
    View in: PubMed
    Score: 0.022
  10. Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase. Antiviral Res. 2021 09; 193:105142.
    View in: PubMed
    Score: 0.022
  11. In vitro activity of itraconazole against SARS-CoV-2. J Med Virol. 2021 Jul; 93(7):4454-4460.
    View in: PubMed
    Score: 0.022
  12. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Antiviral Res. 2021 09; 193:105127.
    View in: PubMed
    Score: 0.022
  13. A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents. Antiviral Res. 2021 08; 192:105122.
    View in: PubMed
    Score: 0.022
  14. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors. Eur J Med Chem. 2021 Oct 05; 221:113494.
    View in: PubMed
    Score: 0.022
  15. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine. 2021 Apr; 66:103288.
    View in: PubMed
    Score: 0.022
  16. SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nat Chem Biol. 2021 02; 17(2):222-228.
    View in: PubMed
    Score: 0.021
  17. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26955-26965.
    View in: PubMed
    Score: 0.021
  18. Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry. Antiviral Res. 2020 10; 182:104924.
    View in: PubMed
    Score: 0.021
  19. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nat Commun. 2020 08 26; 11(1):4253.
    View in: PubMed
    Score: 0.021
  20. A prospect on the use of antiviral drugs to control local outbreaks of COVID-19. BMC Med. 2020 06 25; 18(1):191.
    View in: PubMed
    Score: 0.021
  21. Medical treatment options for COVID-19. Eur Heart J Acute Cardiovasc Care. 2020 Apr; 9(3):209-214.
    View in: PubMed
    Score: 0.020
  22. a-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment. J Med Chem. 2020 05 14; 63(9):4562-4578.
    View in: PubMed
    Score: 0.020
  23. Isolation of phenanthrenes and identification of phorbol ester derivatives as potential anti-CHIKV agents using FBMN and NAP from Sagotia racemosa. Phytochemistry. 2019 Nov; 167:112101.
    View in: PubMed
    Score: 0.019
  24. A Viral Polymerase Inhibitor Reduces Zika Virus Replication in the Reproductive Organs of Male Mice. Int J Mol Sci. 2019 Apr 29; 20(9).
    View in: PubMed
    Score: 0.019
  25. Structural and functional similarities in bunyaviruses: Perspectives for pan-bunya antivirals. Rev Med Virol. 2019 05; 29(3):e2039.
    View in: PubMed
    Score: 0.019
  26. Antiviral Compounds from Codiaeum peltatum Targeted by a Multi-informative Molecular Networks Approach. J Nat Prod. 2019 02 22; 82(2):330-340.
    View in: PubMed
    Score: 0.019
  27. Favipiravir inhibits in vitro Usutu virus replication and delays disease progression in an infection model in mice. Antiviral Res. 2018 12; 160:137-142.
    View in: PubMed
    Score: 0.018
  28. A Single Nucleoside Viral Polymerase Inhibitor Against Norovirus, Rotavirus, and Sapovirus-Induced Diarrhea. J Infect Dis. 2018 10 20; 218(11):1753-1758.
    View in: PubMed
    Score: 0.018
  29. Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors. J Med Chem. 2018 09 27; 61(18):8390-8401.
    View in: PubMed
    Score: 0.018
  30. Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication. J Med Chem. 2018 09 27; 61(18):8402-8416.
    View in: PubMed
    Score: 0.018
  31. Antiviral effect of the nucleoside analogue cidofovir in the context of sexual transmission of a gammaherpesvirus in mice. J Antimicrob Chemother. 2018 08 01; 73(8):2095-2103.
    View in: PubMed
    Score: 0.018
  32. Antiplasmodial, anti-chikungunya virus and antioxidant activities of 64 endemic plants from the Mascarene Islands. Int J Antimicrob Agents. 2018 Nov; 52(5):622-628.
    View in: PubMed
    Score: 0.018
  33. Identification of fukinolic acid from Cimicifuga heracleifolia and its derivatives as novel antiviral compounds against enterovirus A71 infection. Int J Antimicrob Agents. 2019 Feb; 53(2):128-136.
    View in: PubMed
    Score: 0.018
  34. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds. ChemMedChem. 2018 07 18; 13(14):1371-1376.
    View in: PubMed
    Score: 0.018
  35. Rational modifications on a benzylidene-acrylohydrazide antiviral scaffold, synthesis and evaluation of bioactivity against Chikungunya virus. Eur J Med Chem. 2018 Apr 10; 149:56-68.
    View in: PubMed
    Score: 0.017
  36. Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. ACS Infect Dis. 2018 04 13; 4(4):605-619.
    View in: PubMed
    Score: 0.017
  37. Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold. Eur J Med Chem. 2018 Mar 25; 148:453-464.
    View in: PubMed
    Score: 0.017
  38. Design, synthesis and evaluation against Chikungunya virus of novel small-molecule antiviral agents. Bioorg Med Chem. 2018 02 15; 26(4):869-874.
    View in: PubMed
    Score: 0.017
  39. Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replication. Mol Pharmacol. 1998 Jan; 53(1):157-65.
    View in: PubMed
    Score: 0.017
  40. Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection. Antiviral Res. 2018 01; 149:113-117.
    View in: PubMed
    Score: 0.017
  41. Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental study. Eur J Med Chem. 2017 Nov 10; 140:528-541.
    View in: PubMed
    Score: 0.017
  42. Fluorination of Naturally Occurring N6-Benzyladenosine Remarkably Increased Its Antiviral Activity and Selectivity. Molecules. 2017 Jul 20; 22(7).
    View in: PubMed
    Score: 0.017
  43. Isolation of Premyrsinane, Myrsinane, and Tigliane Diterpenoids from Euphorbia pithyusa Using a Chikungunya Virus Cell-Based Assay and Analogue Annotation by Molecular Networking. J Nat Prod. 2017 07 28; 80(7):2051-2059.
    View in: PubMed
    Score: 0.017
  44. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication. J Med Chem. 2017 07 13; 60(13):5472-5492.
    View in: PubMed
    Score: 0.017
  45. Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1. Antiviral Res. 2017 08; 144:216-222.
    View in: PubMed
    Score: 0.017
  46. Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase. J Virol. 2017 06 15; 91(12).
    View in: PubMed
    Score: 0.017
  47. Chikungunya virus infections: time to act, time to treat. Curr Opin Virol. 2017 06; 24:25-30.
    View in: PubMed
    Score: 0.016
  48. Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases. J Med Chem. 2017 02 23; 60(4):1400-1416.
    View in: PubMed
    Score: 0.016
  49. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307. Antiviral Res. 2017 04; 140:37-44.
    View in: PubMed
    Score: 0.016
  50. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication. Antiviral Res. 2017 04; 140:1-12.
    View in: PubMed
    Score: 0.016
  51. Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCV. Bioorg Med Chem Lett. 2017 02 15; 27(4):936-940.
    View in: PubMed
    Score: 0.016
  52. Structure-activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid. Antiviral Res. 2017 Mar; 139:32-40.
    View in: PubMed
    Score: 0.016
  53. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. Gastroenterology. 2016 Jan; 150(1):82-85.e4.
    View in: PubMed
    Score: 0.015
  54. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity. Bioorg Med Chem Lett. 2015 Aug 01; 25(15):2923-6.
    View in: PubMed
    Score: 0.014
  55. The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family. PLoS Pathog. 2015 Mar; 11(3):e1004733.
    View in: PubMed
    Score: 0.014
  56. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014 Aug; 58(8):4875-84.
    View in: PubMed
    Score: 0.013
  57. Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication. Eur J Med Chem. 2011 Sep; 46(9):4281-8.
    View in: PubMed
    Score: 0.011
  58. Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics. J Antimicrob Chemother. 2011 Jun; 66(6):1287-94.
    View in: PubMed
    Score: 0.011
  59. 3'-Deoxy phosphoramidate dinucleosides as improved inhibitors of hepatitis C virus subgenomic replicon and NS5B polymerase activity. J Med Chem. 2010 Sep 23; 53(18):6608-17.
    View in: PubMed
    Score: 0.010
  60. Synthesis of 6-arylthio analogs of 2',3'-dideoxy-3'-fluoroguanosine and their effect against hepatitis B virus replication. Nucleosides Nucleotides Nucleic Acids. 2006; 25(4-6):655-65.
    View in: PubMed
    Score: 0.008
  61. Antiviral activity of ganciclovir elaidic acid ester against herpesviruses. Antiviral Res. 2000 Mar; 45(3):157-67.
    View in: PubMed
    Score: 0.005
  62. Structurally Diverse Diterpenoids from Sandwithia guyanensis. J Nat Prod. 2018 04 27; 81(4):901-912.
    View in: PubMed
    Score: 0.004
  63. New class of early-stage enterovirus inhibitors with a novel mechanism of action. Antiviral Res. 2017 Nov; 147:67-74.
    View in: PubMed
    Score: 0.004
  64. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004 Oct 08; 323(1):264-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.